State of New Jersey Common Pension Fund D
CTMX icon

State of New Jersey Common Pension Fund D’s CytomX Therapeutics CTMX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Buy
52,424
+20,576
+65% +$78.6K ﹤0.01% 1702
2026
Q1 		$150K Buy
+31,848
New +$162K ﹤0.01% 1542

Other funds holding CTMX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

State of New Jersey Common Pension Fund D's CTMX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D increased its CytomX Therapeutics (CTMX) stake by 65% in Q2 2026, buying an estimated $78.6K and bringing the position to 52,424 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

State of New Jersey Common Pension Fund D first reported a position in CTMX in Q1 2026 and has held it in 2 quarters since. 44 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 52,424 shares of CytomX Therapeutics worth $197K as of Q2 2026.
  • State of New Jersey Common Pension Fund D bought 20,576 CytomX Therapeutics shares in Q2 2026, an estimated $78.6K.
  • CytomX Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1702 holding.
  • State of New Jersey Common Pension Fund D first reported a position in CytomX Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 44 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.